UBE2L6 plays a critical role in the development of esophageal cancer and in the regulation of fatty acid metabolism, which is significant for tumor progression. These findings enhance our molecular understanding of UBE2L6 and provide a new direction for developing precise therapeutic strategies based on metabolic regulation, potentially leading to more treatment options for patients with esophageal cancer.